Everspin Technologies (MRAM) Q1 2026: $40M Defense Contract Expands Visibility, Capacity Roadmap
Everspin’s quarter delivered above-guidance revenue and marked a strategic inflection with a new $40 million defense contract, deepening its role in critical infrastructure and onshoring. Product sales growth and margin expansion highlight strong demand in industrial, transportation, and data center end-markets, while new partnerships and product launches set the stage for multi-year scale and diversification. Capital allocation and operational discipline remain crucial as litigation and CapEx weigh on near-term cash flow.
Summary
- Defense Contract Unlocks Multi-Year Revenue: New $40 million deal with a US prime contractor reinforces Everspin’s positioning in aerospace and defense supply chains.
- Product Sales Drive Margin Expansion: Strong industrial, transportation, and data center demand lift product revenue and utilization, supporting 50%+ gross margin targets.
- Capacity and Product Roadmap Accelerate: Microchip foundry agreement and Unisys MRAM launch extend addressable market and supply resilience into 2027 and beyond.
Performance Analysis
Everspin delivered first-quarter results at the high end of guidance, with revenue advancing on robust demand across industrial automation, transportation, and data center verticals. Product sales—comprising both toggle and STT MRAM—surged 28% year over year, reflecting design wins transitioning to production and inventory normalization, particularly in Japan and Asia. The company’s MRAM, magnetoresistive random-access memory, is gaining traction in mission-critical applications such as railway signal systems and data center RAID modules, where reliability and non-volatility are essential.
Gross margin improved to 52.7% versus the prior year, attributed to higher capacity utilization and operational leverage as volumes increased. Licensing and royalty revenue, however, declined, underscoring a shift toward product-driven growth. Operating expenses rose, primarily due to litigation and compensation costs, which also pressured operating cash flow. Despite a $4 million sequential cash decline, Everspin remains debt-free and maintains a $40.5 million cash balance, supporting its ongoing investment in capacity and product development.
- Industrial and Transportation Outperformance: Recovery in automation and new rail transit deployments fueled segment growth, validating MRAM’s value in harsh environments.
- Data Center Engagements: Continued collaboration with IBM and hyperscale operators underpins relevance in storage-intensive applications.
- Operating Expense Drag: Litigation and higher personnel costs elevated opex, impacting cash conversion despite revenue gains.
Other income from government contracts continues to supplement results but is expected to wind down by mid-2027, shifting the revenue mix further toward commercial product sales.
Executive Commentary
"Today after market close, we announced a new two and a half year, 40 million agreement with a US prime contractor. Under the agreement, Everspin will be a subcontractor on an existing prime contract and will provide process technology capabilities and engineering services for US defense industrial based customers."
Sanjeev Agarwal, President and Chief Executive Officer
"Our results reflect the consistency of our execution. During the first quarter, we delivered revenue of $14.9 million, up 14% year over year, and toward the high end of our guidance range of $14 to $15 million, driven by higher product sales."
Bill Cooper, Chief Financial Officer
Strategic Positioning
1. Deepening Defense and Aerospace Integration
The $40 million subcontract with a US prime contractor cements Everspin as a core supplier to the defense industrial base, providing not only MRAM products but also process technology and engineering services. This deal, alongside the ongoing $14.6 million DOD sustainment contract, signals the company’s value as a domestic, reliable source for mission-critical memory and supply chain resilience.
2. Onshore Capacity Expansion via Microchip Partnership
The 10-year foundry agreement with Microchip will establish a second US-based MRAM production line, reducing single-site risk and supporting long-term growth. This move is directly responsive to increased demand and government emphasis on domestic semiconductor production, with initial shipments from the Oregon fab expected in 2027.
3. Product Roadmap: Unisys MRAM and High-Reliability Devices
The Unisys MRAM family launch targets a $3 billion NOR flash market, aiming for a 5–10% share in the early years. Engineering samples are slated for late 2026, with customer qualification cycles extending revenue realization into 2027 and beyond. High-reliability parts for aerospace and industrial uses are also progressing toward volume production, further broadening the portfolio.
4. Operational Discipline Amid Litigation and CapEx Cycles
Ongoing litigation and professional fees are pressuring near-term cash flow and opex. However, management signals that CapEx intensity will moderate after recent Chandler facility upgrades, with future spend aligned to the Microchip foundry ramp and manageable within historical levels.
Key Considerations
Everspin’s quarter is defined by the intersection of robust product demand, strategic contract wins, and critical investments in capacity and technology. The company is deliberately shifting its revenue mix toward product sales while leveraging government and defense relationships for margin stability and long-term visibility.
Key Considerations:
- Defense Contract Multiplier: The $40 million agreement provides multi-year revenue and margin support, but the precise revenue cadence and milestone risks remain to be detailed.
- Product-Led Growth: Sustained demand in industrial, transportation, and data center channels is accelerating the transition from licensing to product-driven revenue, enhancing operational leverage.
- Capacity Investment Timing: The Microchip foundry build-out will require stepped CapEx over two years, but management expects this to be within historic norms and necessary for future scale.
- Litigation Expense Overhang: Elevated legal costs are expected to persist in the near term, potentially constraining cash flow despite underlying business momentum.
Risks
Execution risk around the $40 million defense contract remains, particularly regarding milestone achievement and integration of technology transfer. Litigation costs could continue to weigh on profitability and cash flow. Customer qualification cycles for new products like Unisys MRAM may delay commercial ramp, while macro or geopolitical shifts could impact government-related demand or foundry project timelines.
Forward Outlook
For Q2 2026, Everspin guided to:
- Total revenue of $15.5 million to $16.5 million (excluding new subcontract impact)
- GAAP net loss per share between $0.12 and $0.07; non-GAAP between break-even and $0.03 per share
For full-year 2026, management did not update formal guidance but:
- Reiterated 50%+ gross margin target
- Confirmed ongoing investment in capacity and product development
Management highlighted that the new defense contract will begin to impact results in the coming quarters, with further detail expected after Q2 as milestones and revenue recognition become clearer. Litigation costs are anticipated to remain elevated for at least the next couple of quarters.
Takeaways
Everspin’s Q1 marked a strategic pivot with new defense wins, robust commercial traction, and tangible progress on supply chain resilience. The company is executing on its shift toward product-led growth while navigating operational and legal headwinds.
- Defense Revenue Visibility: The $40 million contract materially extends revenue visibility and underscores Everspin’s strategic value in the US defense ecosystem.
- Product and Capacity Momentum: Growth in MRAM product sales and the Microchip partnership position Everspin for scale and diversification as new markets come online.
- Watch for Execution on Milestones and Cash Flow: Investors should monitor the cadence of defense contract revenue, litigation expense trends, and the ramp of new product lines and foundry capacity through 2027.
Conclusion
Everspin is leveraging government and commercial tailwinds to drive a multi-year transformation toward higher-margin, product-led growth. While legal and CapEx cycles introduce near-term volatility, the company’s strategic positioning in defense, industrial, and data center markets provides a strong foundation for future expansion.
Industry Read-Through
Everspin’s results highlight the increasing premium on domestic, resilient semiconductor supply chains, particularly for defense and critical infrastructure. The company’s ability to secure long-term government contracts and partner with foundry operators like Microchip signals a broader industry trend of onshoring and technology transfer as national security priorities intensify. For memory and specialty semiconductor peers, the quarter underscores the value of aligning product roadmaps and capacity investments with both commercial and government demand, as well as the importance of operational discipline amid litigation and CapEx cycles. The extended customer qualification periods for new memory products also serve as a reminder that revenue realization in these markets can lag development by several years.